Literature DB >> 11714853

Hydrogenated fat consumption affects acylation-stimulating protein levels and cholesterol esterification rates in moderately hypercholesterolemic women.

N R Matthan1, K Cianflone, A H Lichtenstein, L M Ausman, M Jauhiainen, P J Jones.   

Abstract

To determine whether hydrogenated fat consumption alters triglyceride metabolism and cholesterol esterification rates, 14 women (65-71 years of age) were provided with each of four diets for 5-week periods according to a randomized cross-over design. The experimental diets contained either soybean oil (SO), low trans squeeze (SQM), medium trans tub (TM), or high trans stick (SM) margarines. Triglyceride uptake by adipose tissue was determined by measuring plasma acylation-stimulating protein (ASP), FFA, glucose, and insulin levels, while rates of transfer and esterification rate of newly synthesized cholesterol (ER) were derived by using plasma CETP levels and the deuterium incorporation methodology. Plasma ASP levels were lowest (P < 0.05) in subjects on the SM diet (33.4 +/- 12.7 nM) compared with the SO (48.7 +/- 17.0 nM) and SQM (50.7 +/- 15.7 nM) diets. Conversely, FFA were highest (P < 0.05) on the SM diet (0.86 +/- 0.45 mM) relative to all the other diets. No differences were observed in plasma glucose and insulin levels among diets. A trend toward higher CETP levels after consumption of the SM diet was observed. However, the ER was lowest (P < 0.05) after the SM (0.111 +/- 0.062 g x day(-1)) diet and highest after consumption of the SQM (0.216 +/- 0.123 g x day(-1)) diet. In addition, ASP levels were negatively correlated with FFA (r = -0.63, P < 0.05), LDL cholesterol (r = -0.56, P < 0.05), and TG (r = -0.41, P < 0.05), whereas FFA was positively correlated with apolipoprotein B-containing lipoproteins (r = 0.58 and 0.47, for VLDL and LDL cholesterol, P < 0.05), and negatively correlated with HDL cholesterol (r = -0.51, P < 0.05). The ER was found to positively correlate with HDL cholesterol and HDL2 subfraction (r = 0.53 and 0.45, respectively, P < 0.05). Taken together, these data demonstrate that the alterations in circulating lipid levels, commonly observed with consumption of hydrogenated fat-rich diets, can be explained in part by changes in ASP activity as well as newly synthesized cholesterol ER.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714853

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

Review 1.  Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis.

Authors:  Antonie J H H M van Oostrom; Jeroen van Wijk; Manuel Castro Cabezas
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 2.  Dietary trans fatty acids and cardiovascular disease risk: past and present.

Authors:  Alice H Lichtenstein
Journal:  Curr Atheroscler Rep       Date:  2014-08       Impact factor: 5.113

Review 3.  Trans fatty acids: effects on cardiometabolic health and implications for policy.

Authors:  R Micha; D Mozaffarian
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2008-11-08       Impact factor: 4.006

Review 4.  Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes.

Authors:  Renata Micha; Dariush Mozaffarian
Journal:  Nat Rev Endocrinol       Date:  2009-04-28       Impact factor: 43.330

5.  Hydrogenated fat intake during pregnancy and lactation caused increase in TRAF-6 and reduced AdipoR1 in white adipose tissue, but not in muscle of 21 days old offspring rats.

Authors:  Juliana L de Oliveira; Lila M Oyama; Ana Cláudia L Hachul; Carolina Biz; Eliane B Ribeiro; Claudia M Oller do Nascimento; Luciana P Pisani
Journal:  Lipids Health Dis       Date:  2011-01-25       Impact factor: 3.876

6.  Effects of sugar-sweetened beverages on plasma acylation stimulating protein, leptin and adiponectin: relationships with metabolic outcomes.

Authors:  Reza Rezvani; Katherine Cianflone; John P McGahan; Lars Berglund; Andrew A Bremer; Nancy L Keim; Steven C Griffen; Peter J Havel; Kimber L Stanhope
Journal:  Obesity (Silver Spring)       Date:  2013-06-13       Impact factor: 5.002

7.  Beneficial effect on serum cholesterol levels, but not glycaemic regulation, after replacing SFA with PUFA for 3 d: a randomised crossover trial.

Authors:  Line Gaundal; Mari C W Myhrstad; Lena Leder; Marte Gjeitung Byfuglien; Terje Gjøvaag; Ida Rud; Kjetil Retterstøl; Kirsten B Holven; Stine M Ulven; Vibeke H Telle-Hansen
Journal:  Br J Nutr       Date:  2020-09-02       Impact factor: 3.718

Review 8.  Modification of High-Density Lipoprotein Functions by Diet and Other Lifestyle Changes: A Systematic Review of Randomized Controlled Trials.

Authors:  Albert Sanllorente; Camille Lassale; Maria Trinidad Soria-Florido; Olga Castañer; Montserrat Fitó; Álvaro Hernáez
Journal:  J Clin Med       Date:  2021-12-15       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.